Universal Nasal Spray Vaccine vs COVID Flu | AcademicJobs
Explore Stanford's groundbreaking nasal spray vaccine offering broad protection against respiratory viruses, bacteria, and allergens.
No reviews yet. Be the first to rate Bali!
Bali Pulendran is the Violetta L. Horton Professor at the Stanford University School of Medicine and serves as Director of the Institute for Immunity, Transplantation and Infection. He holds appointments as Professor of Pathology and Professor of Microbiology and Immunology. Pulendran joined Stanford in 2017 and assumed the directorship of the institute in 2024. His laboratory investigates the mechanisms by which the innate immune system regulates adaptive immunity and applies systems biological approaches to understand and predict immune responses to vaccination and infection in humans.
Pulendran earned a BA (Hons) in Natural Sciences from Cambridge University in 1988 and a PhD in Immunology from the Walter & Eliza Hall Institute at the University of Melbourne in 1995. Prior to Stanford, he held positions at Emory University, including as the Charles Howard Candler Professor of Pathology and Laboratory Medicine and director of the innate immunity program at the Emory Vaccine Center. His research has been published in leading journals including Nature, Science, Cell, Nature Medicine, and Nature Immunology, and he has received support from the National Institutes of Health and the Bill & Melinda Gates Foundation.
Explore Stanford's groundbreaking nasal spray vaccine offering broad protection against respiratory viruses, bacteria, and allergens.
Stanford's new universal respiratory vaccine in Science journal protects mice against COVID, flu-like viruses, bacteria, and allergens. Explore implications for US public health and higher ed research careers.
Stanford Medicine's Feb 2026 study unveils a universal nasal spray vaccine protecting mice from viruses, pneumonia bacteria, and allergens—paving the way for human trials and transforming higher ed research careers.